{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:19:21Z","timestamp":1762521561571},"reference-count":52,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2013,4,25]],"date-time":"2013-04-25T00:00:00Z","timestamp":1366848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Digest Diseases"],"published-print":{"date-parts":[[2013,6]]},"abstract":"<jats:p>Crohn's disease and ulcerative colitis are chronic inflammatory bowel diseases that have been treated with corticosteroids, 5\u2010aminosalicates and thiopurines, but therapeutic options have been broadened with the arrival of anti\u2010tumor necrosis factor antibodies. In this article we reviewed the current evidence\u2010based approach to inflammatory bowel disease, the modifications that have been made to existing therapies and discussed new drugs that have shown success in clinical trials. The new drugs discussed here are those that disturb lymphocyte homing to the gut (natalizumab, vedolizumab and anti\u2010mucosal addressin cellular adhesion molecule); one that blocks interleukin (<jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>)\u201012 as well as the <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201023\/T helper 17 (Th17) axis (ustekinumab) and one that blocks the signaling of multiple cytokines (tofacitinib).<\/jats:p>","DOI":"10.1111\/1751-2980.12048","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T18:10:45Z","timestamp":1361297445000},"page":"282-287","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Recent developments in the treatment of inflammatory bowel disease"],"prefix":"10.1111","volume":"14","author":[{"given":"Svend T.","family":"Rietdijk","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology Academic Medical Center, University of Amsterdam  Amsterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert R.","family":"D'Haens","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology Academic Medical Center, University of Amsterdam  Amsterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,4,25]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.58"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.73"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.10.032"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12145"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.09.002"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000478.pub3"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2009.12.002"},{"issue":"1","key":"e_1_2_6_9_1","article-title":"Azathioprine or 6\u2010mercaptopurine for maintenance of remission in Crohn's disease","author":"Prefontaine E","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00642.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.060103"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-2980.2012.00576.x"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000158386.25660.1e"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.10.025"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.10.011"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2005.02517.x"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2009.09.007"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.08.003"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X53252"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02879.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.11.032"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026648812439"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.03.024"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.01.014"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067594"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062897"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.06.064"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.04.021"},{"key":"e_1_2_6_29_1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0016-5085(12)60609-X","article-title":"A phase 2\/3 randomized, placebo\u2010controlled, double\u2010blind study to evaluate the safety and efficacy of subcutaneous golimumab induction therapy in patients with moderately to severely active ulcerative colitis: PURSUIT SC","volume":"142","author":"Sandborn WJ","year":"2012","journal-title":"Gastroenterology"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.03.024"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043335"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020732"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.26260"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044396"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044397"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020696"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051782"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107829"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042982"},{"key":"e_1_2_6_40_1","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1016\/S0016-5085(12)60607-6","article-title":"Induction therapy for ulcerative colitis: results of GEMINI I, a randomized, placebo\u2010controlled, double\u2010blind, multicenter phase 3 trial","volume":"142","author":"Feagan BG","year":"2012","journal-title":"Gastroenterology"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.06.007"},{"key":"e_1_2_6_42_1","unstructured":"ColombelJ.Vedolizumab induction therapy for Crohn's disease: results of GEMINI II a randomized placebo\u2010controlled double\u2010blind multicenter phase 3 trial.UEGW 2012 oral presentation 20\u201324 October 2012. Amsterdam The Netherlands."},{"key":"e_1_2_6_43_1","unstructured":"ColombelJ.Vedolizumab maintenance therapy for Crohn's disease: results of GEMINI II a randomized placebo\u2010controlled double\u2010blind multicenter phase 3 trial.UEGW 2012 oral presentation. 20\u201324 October 2012. Amsterdam The Netherlands."},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.226548"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.07.014"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1203572"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.05070.x"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003668"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.33419"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109071"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112072"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112168"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300904"}],"container-title":["Journal of Digestive Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1751-2980.12048","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1751-2980.12048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T19:09:41Z","timestamp":1697396981000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1751-2980.12048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,25]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.1111\/1751-2980.12048"],"URL":"https:\/\/doi.org\/10.1111\/1751-2980.12048","archive":["Portico"],"relation":{},"ISSN":["1751-2972","1751-2980"],"issn-type":[{"value":"1751-2972","type":"print"},{"value":"1751-2980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,25]]},"assertion":[{"value":"2013-04-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}